MiR-223 Promotes Tumor Progression via Targeting RhoB in Gastric Cancer

Table 2

Univariate analyses of prognostic variables of overall survival in GC patients.

Variable	RR	95% CI	value
Age	0.916	0.467–1.797	0.961
Gender	0.953	0.481–1.888	0.890
Tumor location	1.242	0.707–2.182	0.451
Tumor size	1.932	0.872–4.279	0.105
TNM stage	0.188	0.077–0.457	0.001
Live metastasis	6.911	2.903–16.46	0.001
Regional lymph node metastasis	2.064	0.998–4.266	0.044
Histology grade	0.550	0.309–0.979	0.042
Borrmann type	1.656	1.048–2.616	0.031
MiR-223 expression	2.868	1.427–5.766	0.003